Long-Term Renal Survival in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis With Complement C3

Rina Oba1, Go Kanzaki1, Takaya Sasaki1

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Insights

Glomerular C3 deposition in antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) indicates a poorer prognosis. Patients with C3 deposits experienced worse kidney and overall survival rates, highlighting its significance in ANCA-GN progression.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Complement activation is increasingly recognized as a key factor in the development of antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN).
  • The prognostic value of glomerular C3 deposition in ANCA-GN requires further investigation.

Purpose of the Study:

  • To evaluate the clinicopathologic significance of glomerular C3 deposition in patients with ANCA-GN.
  • To determine the prognostic impact of C3 deposition on renal and overall survival in ANCA-GN.

Main Methods:

  • Retrospective analysis of 142 ANCA-GN patients from Japanese hospitals (2004-2020).
  • Glomerular C3 deposition identified via direct immunofluorescence (IF) (staining ≥1+).
  • Composite endpoints: 30% eGFR reduction, ESKD, or death; compared outcomes between C3-positive and C3-negative groups.

Main Results:

  • C3 deposition was present in 39.4% of ANCA-GN kidney biopsies.
  • Patients with C3 deposition showed lower serum C3 levels and significantly worse 5-year event-free survival (log-rank P=0.002).
  • Multivariable analysis confirmed C3 deposition as a significant predictor of adverse outcomes (aHR=2.02, P=0.008), independent of other factors.

Conclusions:

  • Glomerular C3 deposition on immunofluorescence is a significant indicator of worse renal outcomes in ANCA-GN.
  • ANCA-GN patients with C3 deposition exhibit poorer overall survival.
  • C3 deposition is an important prognostic marker in ANCA-GN.
Abstract

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
224
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
129
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
239
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
96
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
86
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
193